Polar Capital Funds PLC - Biotechnology Fund I GBP Hedged Inc

Category Other Equity

This fund can be held in an Investment ISA, SIPP and Investment Account

Last buy/sell price

-

arrow-down£-0.14 (-0.81%)

Fund Code

POBIH

BFX4HX5

IE00BFX4HX56

Prices updated as at 18 Apr 2024

Prices in GBP

Investment objective

The investment objective of the Fund is to preserve capital and achieve long term capital appreciation.

Important documents: Please ensure that you have read the Key Information Document/Technical Guide , Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Fund status	Open
Fund type	Open Ended Investment Company
Fund manager	David Pinniger, Gareth Powell
	19.6
	13.45
Fund comparative index	NASDAQ Biotechnology NR USD
	Specialist
	-
	1.12
	0.05
	0.00
	Other Equity
	10
Fund provider	Polar Capital LLP
Share class launch date	17 Jan 2018
	£1.43b
	-
	-
	-
	Annually

Please note that some funds may have small additional incidental charges that are not shown here. Where these charges do exist they are included within the variable ongoing costs in the Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.